CD8+ T cell exhaustion and cancer immunotherapy
Q Wang, Y Qin, B Li - Cancer letters, 2023 - Elsevier
Immunotherapy plays an increasingly important role in the treatment of most malignant
tumors, and CD8+ T cells are the most important antitumor effector cells in the process of …
tumors, and CD8+ T cells are the most important antitumor effector cells in the process of …
[HTML][HTML] The role of CD8+ T-cells in colorectal cancer immunotherapy
T He, C Hu, S Li, Y Fan, F Xie, X Sun, Q Jiang, W Chen… - Heliyon, 2023 - cell.com
Immunotherapy has been an advanced and effective approach to treating various types of
solid tumors in recent years, and the most successful strategy is immune checkpoint …
solid tumors in recent years, and the most successful strategy is immune checkpoint …
Spatial transcriptomic analysis of tumour–immune cell interactions in melanoma arising from congenital melanocytic nevus
Y Lim, BK Cho, SJ Kang, S Jeong… - Journal of the …, 2024 - Wiley Online Library
Background Studies on the interaction between tumour‐infiltrating immune cells (TIICs) and
tumour cells in melanoma arising from congenital melanocytic nevus (CMN) are lacking …
tumour cells in melanoma arising from congenital melanocytic nevus (CMN) are lacking …
[HTML][HTML] PVRIG expression is an independent prognostic factor and a new potential target for immunotherapy in hepatocellular carcinoma
DJ Birnbaum, M Picard, Q Da Costa, T Delayre… - Cancers, 2023 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) represents the third cause of cancer-
related death in the world, and identification of new prognostic factors and/or therapeutic …
related death in the world, and identification of new prognostic factors and/or therapeutic …